Jens Nielsen
Vorstandsvorsitzender bei Bioinnovation Institute
Aktive Positionen von Jens Nielsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Chalmers University of Technology | Corporate Officer/Principal | 19.06.2009 | - |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 01.01.2017 | - |
Gründer | 01.01.2017 | - | |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Jens Nielsen
Ehemalige bekannte Positionen von Jens Nielsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Direktor/Vorstandsmitglied | 19.10.2009 | 08.08.2013 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 19.06.2009 | |
Gründer | 19.10.2009 | 08.08.2013 | |
Corporate Officer/Principal | 19.06.2009 | - | |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | 19.06.2009 | 02.04.2012 |
Vorsitzender | 01.10.2006 | 19.06.2009 | |
Gründer | 08.04.2010 | 02.04.2012 | |
Technical University of Denmark | Direktor/Vorstandsmitglied | 01.01.1998 | 01.01.2006 |
Corporate Officer/Principal | 01.01.2006 | 01.01.2007 | |
MetaboGen AB
MetaboGen AB Internet Software/ServicesTechnology Services MetaboGen AB operates a metagenome and metabolic disease platform. It provides commercial access to metagenome research and development. The firm offers create next generation probiotics and pharmaceutical products, based on the microbiome. The company was founded in 2011 and is headquartered in Göteborg, Sweden. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Jens Nielsen
Danmarks Farmaceutiske Universitet | Doctorate Degree |
Statistik
International
Dänemark | 6 |
Schweden | 4 |
Operativ
Director/Board Member | 5 |
Founder | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Technology Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Health Technology |
MetaboGen AB
MetaboGen AB Internet Software/ServicesTechnology Services MetaboGen AB operates a metagenome and metabolic disease platform. It provides commercial access to metagenome research and development. The firm offers create next generation probiotics and pharmaceutical products, based on the microbiome. The company was founded in 2011 and is headquartered in Göteborg, Sweden. | Technology Services |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | Commercial Services |
- Börse
- Insiders
- Jens Nielsen
- Erfahrung